接受免疫检查点抑制剂治疗的患者的摄入量:食物频率问卷研究
Hirotsugu Ariizumi1, Miyuki Shimazui2, Chisato Ogawa2
1Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Frontiers in immunology
|December 29, 2025
概括
较高的摄入量,而不是纤维,与日本癌症患者更好的免疫检查点抑制剂 (ICI) 反应有关. 这表明,个性化的饮食建议可能会改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 营养科学 营养科学
背景情况:
- 肠道微生物群影响免疫检查点抑制剂 (ICI) 的有效性.
- 饮食因素,特别是纤维,可能会影响微生物组和ICI反应.
- 饮食和ICI反应之间的关系因不同饮食习惯而因人群而异.
研究的目的:
- 调查与日本癌症患者ICI反应相关的饮食成分.
- 为了澄清纤维和其他饮食因素在日本人口中ICI疗效中的作用.
主要方法:
- 32名日本癌症患者接受ICI治疗.
- 在ICI治疗前的营养摄入量使用食物频率问卷进行评估.
- 统计分析确定了与治疗反应独立相关的饮食项目.
主要成果:
- (酸) 摄入量与ICI反应有独立的关联.
- 较高的消费与显著较低的非响应几率相关 (P = 0.017).
- 总和可发酵的食纤维摄入量与ICI疗效或存活率没有显著关联.
结论:
- 增加摄入量与日本患者的ICI反应改善有关.
- 食纤维似乎对ICI在这个人群中的有效性产生了有限的影响.
- 量身定制的饮食策略,可能包括,可能有助于优化ICI治疗结果.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
649
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
649
Assessment of the Gastrointestinal System I: Subjective Data
590
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
590
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
516
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
516
Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Bioavailability Study Design: Healthy Subjects Versus Patients
130
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
130

